{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:34:40Z","timestamp":1791326080559,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:00:00Z","timestamp":1427068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/nbt.3179","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T16:33:19Z","timestamp":1427128399000},"page":"549-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-7463","authenticated-orcid":false,"given":"Laurent","family":"Mailly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Lupberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrick K","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois H T","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Leboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Fofana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Thumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassilo","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Mee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Chane-Woon-Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ericsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pessaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kaderali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-348X","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-4894","authenticated-orcid":false,"given":"Markus H","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Neunlist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam B","family":"Zeisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Dandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A","family":"McKeating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Robinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"BFnbt3179_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.3184","volume":"19","author":"DL Thomas","year":"2013","unstructured":"Thomas, D.L. Global control of hepatitis C: where challenge meets opportunity. Nat. Med. 19, 850\u2013858 (2013).","journal-title":"Nat. Med."},{"key":"BFnbt3179_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","volume":"446","author":"MJ Evans","year":"2007","unstructured":"Evans, M.J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801\u2013805 (2007).","journal-title":"Nature"},{"key":"BFnbt3179_CR3","doi-asserted-by":"publisher","first-page":"15191","DOI":"10.1073\/pnas.261452898","volume":"98","author":"CJ Cohen","year":"2001","unstructured":"Cohen, C.J. et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. USA 98, 15191\u201315196 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3179_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2012.03.001","volume":"11","author":"M Fukumatsu","year":"2012","unstructured":"Fukumatsu, M. et al. Shigella targets epithelial tricellular junctions and uses a noncanonical clathrin-dependent endocytic pathway to spread between cells. Cell Host Microbe 11, 325\u2013336 (2012).","journal-title":"Cell Host Microbe"},{"key":"BFnbt3179_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.virol.2013.08.009","volume":"446","author":"P Che","year":"2013","unstructured":"Che, P., Tang, H. & Li, Q. The interaction between claudin-1 and dengue viral prM\/M protein for its entry. Virology 446, 303\u2013313 (2013).","journal-title":"Virology"},{"key":"BFnbt3179_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/90968","volume":"7","author":"DF Mercer","year":"2001","unstructured":"Mercer, D.F. et al. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7, 927\u2013933 (2001).","journal-title":"Nat. Med."},{"key":"BFnbt3179_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1053\/j.gastro.2010.05.073","volume":"139","author":"I Fofana","year":"2010","unstructured":"Fofana, I. et al. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastroenterology 139, 953\u2013964 (2010).","journal-title":"Gastroenterology"},{"key":"BFnbt3179_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nm1698","volume":"14","author":"M Law","year":"2008","unstructured":"Law, M. et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 14, 25\u201327 (2008).","journal-title":"Nat. Med."},{"key":"BFnbt3179_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2341","volume":"17","author":"J Lupberger","year":"2011","unstructured":"Lupberger, J. et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 17, 589\u2013595 (2011).","journal-title":"Nat. Med."},{"key":"BFnbt3179_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.24692","volume":"55","author":"P Meuleman","year":"2012","unstructured":"Meuleman, P. et al. A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo. Hepatology 55, 364\u2013372 (2012).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1136\/gutjnl-2012-302600","volume":"62","author":"N Shi","year":"2013","unstructured":"Shi, N. et al. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice. Gut 62, 1055\u20131061 (2013).","journal-title":"Gut"},{"key":"BFnbt3179_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/hep.25910","volume":"57","author":"HJ Harris","year":"2013","unstructured":"Harris, H.J., Wilson, G.K., Hubscher, S.G. & McKeating, J.A. Heterogeneous claudin-1 expression in human liver. Hepatology 57, 854\u2013855 (2013).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR13","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/hep.26911","volume":"59","author":"NF Fletcher","year":"2014","unstructured":"Fletcher, N.F. et al. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology 59, 1320\u20131330 (2014).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR14","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1086\/651579","volume":"201","author":"J Bukh","year":"2010","unstructured":"Bukh, J. et al. Challenge pools of hepatitis C virus genotypes 1\u20136 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models. J. Infect. Dis. 201, 1381\u20131389 (2010).","journal-title":"J. Infect. Dis."},{"key":"BFnbt3179_CR15","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","volume":"103","author":"T Pietschmann","year":"2006","unstructured":"Pietschmann, T. et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103, 7408\u20137413 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3179_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791\u2013796 (2005).","journal-title":"Nat. Med."},{"key":"BFnbt3179_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.gastro.2012.04.006","volume":"143","author":"I Fofana","year":"2012","unstructured":"Fofana, I. et al. Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies. Gastroenterology 143, 223\u2013233 (2012).","journal-title":"Gastroenterology"},{"key":"BFnbt3179_CR18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/hep.23445","volume":"51","author":"SE Krieger","year":"2010","unstructured":"Krieger, S.E. et al. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2\u2013CD81-claudin-1 associations. Hepatology 51, 1144\u20131157 (2010).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR19","doi-asserted-by":"crossref","unstructured":"D\u00fcbel, S. & Reichert, J.M. (eds.). Handbook of Therapeutic Antibodies (Wiley-Blackwell, 2014).","DOI":"10.1002\/9783527682423"},{"key":"BFnbt3179_CR20","doi-asserted-by":"publisher","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","volume":"285","author":"HJ Harris","year":"2010","unstructured":"Harris, H.J. et al. Claudin association with CD81 defines hepatitis C virus entry. J. Biol. Chem. 285, 21092\u201321102 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnbt3179_CR21","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1038\/onc.2012.505","volume":"32","author":"Y Suh","year":"2013","unstructured":"Suh, Y. et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene 32, 4873\u20134882 (2013).","journal-title":"Oncogene"},{"key":"BFnbt3179_CR22","doi-asserted-by":"publisher","first-page":"8316","DOI":"10.1128\/JVI.00665-08","volume":"82","author":"M Brazzoli","year":"2008","unstructured":"Brazzoli, M. et al. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J. Virol. 82, 8316\u20138329 (2008).","journal-title":"J. Virol."},{"key":"BFnbt3179_CR23","doi-asserted-by":"publisher","first-page":"10935","DOI":"10.1128\/JVI.00750-12","volume":"86","author":"J Diao","year":"2012","unstructured":"Diao, J. et al. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry. J. Virol. 86, 10935\u201310949 (2012).","journal-title":"J. Virol."},{"key":"BFnbt3179_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.chom.2013.02.006","volume":"13","author":"L Zona","year":"2013","unstructured":"Zona, L. et al. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe 13, 302\u2013313 (2013).","journal-title":"Cell Host Microbe"},{"key":"BFnbt3179_CR25","doi-asserted-by":"publisher","first-page":"e1002829","DOI":"10.1371\/journal.ppat.1002829","volume":"8","author":"N Menzel","year":"2012","unstructured":"Menzel, N. et al. MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles. PLoS Pathog. 8, e1002829 (2012).","journal-title":"PLoS Pathog."},{"key":"BFnbt3179_CR26","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/hep.26770","volume":"59","author":"S Wieland","year":"2014","unstructured":"Wieland, S. et al. Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology 59, 2121\u20132130 (2014).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1126\/science.282.5386.103","volume":"282","author":"AU Neumann","year":"1998","unstructured":"Neumann, A.U. et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282, 103\u2013107 (1998).","journal-title":"Science"},{"key":"BFnbt3179_CR28","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.4049\/jimmunol.181.7.4926","volume":"181","author":"L Lan","year":"2008","unstructured":"Lan, L. et al. Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J. Immunol. 181, 4926\u20134935 (2008).","journal-title":"J. Immunol."},{"key":"BFnbt3179_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/hep.26567","volume":"59","author":"S Haid","year":"2014","unstructured":"Haid, S. et al. Isolate-dependent use of Claudins for cell entry by hepatitis C virus. Hepatology 59, 24\u201334 (2014).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR30","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1128\/JVI.01691-13","volume":"87","author":"I Fofana","year":"2013","unstructured":"Fofana, I. et al. Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies. J. Virol. 87, 10405\u201310410 (2013).","journal-title":"J. Virol."},{"key":"BFnbt3179_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.22028","volume":"47","author":"GM Reynolds","year":"2008","unstructured":"Reynolds, G.M. et al. Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 47, 418\u2013427 (2008).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1128\/JVI.01534-06","volume":"81","author":"G Koutsoudakis","year":"2007","unstructured":"Koutsoudakis, G., Herrmann, E., Kallis, S., Bartenschlager, R. & Pietschmann, T. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J. Virol. 81, 588\u2013598 (2007).","journal-title":"J. Virol."},{"key":"BFnbt3179_CR33","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1128\/JVI.02286-07","volume":"82","author":"HJ Harris","year":"2008","unstructured":"Harris, H.J. et al. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J. Virol. 82, 5007\u20135020 (2008).","journal-title":"J. Virol."},{"key":"BFnbt3179_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/gut.2007.140806","volume":"58","author":"T Piche","year":"2009","unstructured":"Piche, T. et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58, 196\u2013201 (2009).","journal-title":"Gut"},{"key":"BFnbt3179_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hep.26097","volume":"57","author":"MN Zahid","year":"2013","unstructured":"Zahid, M.N. et al. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination. Hepatology 57, 492\u2013504 (2013).","journal-title":"Hepatology"},{"key":"BFnbt3179_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nbt1389","volume":"26","author":"J Petersen","year":"2008","unstructured":"Petersen, J. et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat. Biotechnol. 26, 335\u2013341 (2008).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3179_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2012.05.044","volume":"143","author":"MT Dill","year":"2012","unstructured":"Dill, M.T. et al. Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C. Gastroenterology 143, 777\u2013786 (2012).","journal-title":"Gastroenterology"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.3179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3179","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:30:41Z","timestamp":1684434641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.3179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFnbt3179"],"URL":"https:\/\/doi.org\/10.1038\/nbt.3179","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,23]]},"assertion":[{"value":"1 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Inserm, the University of Strasbourg and Genovac\/Aldevron Freiburg have filed a patent application on monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection (US Patent # 8,518,408; WO2010034812; PCT\/EP2009\/062449). T.F.B. has served as a scientific advisor for Gilead, Biotest and Vironexx.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}